ARCHIVES

NCAB Gives Life To Three CBCCP Contractors Marked For Termination; Compromise “Reasonable” – DeVita

This article is from The Cancer Letter archive.

Vol. 06 No. 22 | May 30, 1980

Download PDF Visit The Full Archive

Related Articles

Panel Calls For New Office, Advisory Groups To Oversee NCI’s Translational Research.

June 22, 2007

GSK Vaccine Prevents Lesions Associated With HPV

July 28, 2006

Interactive R01 Scores Vary widely, Result Of separate Review

June 11, 1993

HHS Task Force Says NCI Drug Program Effective, Otters Suggestions; DeVita Responds

March 26, 1982

Gore, Agency Report, Support Legislation To Protect Genetic Info

January 30, 1998

“Triple-Negative” Should Be Split Into Subtypes, Say Researchers

February 22, 2013